Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells

Annals of Surgery

Volumn 247, Issue 2, 2008, Pages 310-314

  Ritter, Edmond ^a   Perry, Adam ^a   Yu, Jack ^a   Wang, Thomas ^a   Tang, Lawton ^b   Bieberich, Erhard ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER INFILTRATION; CANCER STEM CELL; CELL ASSAY; CELL MIGRATION; CELL STRAIN MCF 7; CELL TYPE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; BONE MARROW CELLS; BREAST NEOPLASMS; CELL MOVEMENT; CHEMOTACTIC FACTORS; CULTURE MEDIA, CONDITIONED; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; STROMAL CELLS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 38549117257     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31816401d5     Document Type: Article

References (29)

1. Studeny M, Marini FC, Dembinski JL, et al. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004;96:1593-1603.
2. 2-stimulated neural progenitors. J Cell Biol. 2003;163:1375-1384.
3. Zimering MB, Thakker-Varia S. Increased fibroblast growth factor-like autoantibodies in serum from a subset of patients with cancer-associated hypercalcemia. Life Sci. 2002;71:2939-2959.
4. 2) promote migration and neurite growth of mouse cochlear ganglion cells in vitro: immunohistochemistry and antibody perturbation. J Neurosci Res. 2000;62:40-55.
5. Facchiano A, De Marchis F, Turchetti E, et al. The chemotactic and mitogenic effects of platelet-derived growth factor-BB on rat aorta smooth muscle cells are inhibited by basic fibroblast growth factor. J Cell Sci. 2000;113(Pt 16):2855-2863.
6. Peister A, Mellad J, Larson B, et al. Adult stem cells from bone marrow (MSC's) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004;103:1662-1668.
7. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2:REVIEWS3005.
8. Powers CJ, McLeskey SW, Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 2000;7:165-197.
9. Prockop D. Marrow stromal cells as stem cells for nonhemiatopoietic tissues. Science. 1997;276:71-74.
10. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
11. Pittenger MF, Mosca JD, McIntosh KR. Human mesenchymal stem cells: progenitor cells for cartilage, bone, fat and stroma. Curr Top Microbiol Immunol. 2000;251:3-11.
12. Studeny M, Marini FC, Champlin RE, et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002;62:3603-3608.
13. Lokshin A, Mayotte J, Levitt M. Mechanism of interferon beta-induced squamous differentiation and programmed cell death in human non-small-cell lung cancer cell lines. J Natl Cancer Inst. 1995;87:206-212.
14. Horwitz EM, Prockop D, Fitzpatrick L, et al. Transplantability and therapeutic effects of bone marrow-derived stem cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309-313.
15. Liechty K, Mackenzie T, Shaaban A, et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med. 2000;6:1282-1286.
16. Fierro FA, Sierralta WD, Epunan MJ, et al. Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis. 2004;21:313-319.
17. Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001;410:50-56.
18. Takei Y, Higashira H, Yamamoto T, et al. Mitogenic activity toward human breast cancer cell line MCF-7 of two bFGFs purified from sera of breast cancer patients: co-operative role of cathepsin D. Breast Cancer Res Treat. 1997;43:53-63.
19. 2 signaling involved in the invasive and tumorigenic behavior of carcinoma cells. Mol Biol Cell. 2004;15:4725-4734.
20. Penault-Llorca F, Bertucci F, Adelaide J, et al. Expression of FGF and FGF receptor genes in human breast cancer. Int J Cancer. 1995;61:170-176.
21. Nicolini A, Campani D, Miccoli P, et al. Vascular endothelial growth factor (VEGF) and other common tissue prognostic indicators in breast cancer: a case-control study. Int J Biol Markers. 2004;19:275-281.
22. Shan S, Robson ND, Cao Y, et al. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival. FASEB J. 2004;18:326-328.
23. Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1, and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006;203:2201-2213.
24. Kruger JA, Kaplan CD, Luo Y, et al. Characterization of stem cell like cancer cells in immune competent mice. Blood. 2006;108:3906-3912.
25. De Raeve H, Van Marck E, Van Camp B, et al. Angiogenesis and the role of bone marrow endothelial cells in haematological malignancies. Histol Histopathol. 2004;19:935-950.
26. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004;95:9-20.
27. Shibata A, Nagaya T, Imai T, et al. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat. 2002;73:237-243.
28. 2 in human tumor cell lines. Int J Cancer. 1999;81:451-458.
29. Yoshimura N, Sano H, Hashiramoto A, et al. The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. Clin Immunol Immunopathol. 1998; 89:28-34.